Since the news broke about Avandia’s link to serious health complications, many patients have considered filing Avandia lawsuits.
If you’re thinking about an Avandia lawsuit, contact the unsafe drug litigation attorneys at Anapol Schartz for a free evaluation of your case.
More About Avandia :
» Avandia Resources on the Web
According to the Centers for Disease Control and Prevention, heart attacks (myocardial infarction) are the number-one non-injury killer in the United States. Nearly 700,000 Americans die each year from heart attacks, and heart attack survivors come away with pain, disabilities and weakened hearts that could lead to a stroke or another heart attack.
Our nation’s 20 million Type II diabetics are at an even higher risk for a heart attack because of the strain that insulin resistance and its symptoms can put on the body. The American Diabetes Association estimates that two out of every three diabetics die of cardiovascular disease. Controlling diabetes and its symptoms is a key part of the way diabetics and their doctors try to lower their risk of a heart attack or other cardiovascular diseases.
Unfortunately, scientists have discovered that one drug prescribed to control diabetes and its risk of heart problems, Avandia, may actually cause heart attacks. A study published in May of 2007 in the New England Journal of Medicine found that Avandia (which doctors call rosiglitazone) increases patients’ risk of a heart attack by 43 percent. It also found that Avandia users’ risk of death from cardiovascular problems -- including heart attacks -- was increased by 64 percent. In response, the U.S. Food and Drug Administration required Avandia’s manufacturer, GlaxoSmithKline, to include a black box warning on its label and issued new safety warnings for the drug.
Doctors are now being warned to avoid prescribing Avandia to patients who have heart problems or take nitrates. The agency has strengthened those warnings twice, most recently in November of 2007; Congress is now investigating the drug’s approval process. In a report issued in June 2007, the FDA suggested that Avandia may have caused at least 83,000 avoidable heart attacks since it entered the market in 1999.
If you or someone you care about has suffered a heart attack, you know how serious they are. Heart attacks are painful, life-threatening and frightening; survivors are at a huge risk for another myocardial infarction, a stroke, kidney problems or other cardiac disease. Some survivors may have permanent health problems that lower their quality of life; most will need to make big lifestyle changes to prevent another attack. And of course, the medical care for the heart attack and ongoing preventive treatment is not cheap. But what if this physical pain, emotional stress and financial strain could all have been prevented? What if the drug manufacturer had been willing to pay for more safety research, or at least be more honest about its product?
That’s the question that confronts Avandia users and their loved ones, as evidence grows that GlaxoSmithKline, Avandia’s manufacturer, may have known about the drug’s safety problems for years. Dr. John Buse, a diabetes expert who heads the University of North Carolina’s Department of Endocrinology and Metabolism, testified to Congress that he spoke out about possible cardiac safety problems with Avandia in 1999. After his remarks at a medical convention, Dr. Buse said, the drug’s manufacturer threatened to sue him, citing a dramatic drop in their stock’s price. The next year, the doctor sent a letter with his concerns to the FDA, but the agency took no action until 2007. In its May 2007 safety warning about Avandia, the FDA cited “recent” information it had received from GlaxoSmithKline showing a 30-40 percent increase in the risk of heart attacks in Avandia users.
Until these safety concerns arose, Avandia was one of the world’s most popular diabetes drugs, the most popular drug in its U.S. market and generated $3 billion a year in sales worldwide. But sales have fallen, and more and more angry patients and their families are considering filing Avandia lawsuits. Avandia litigation can help patients hold drug makers responsible for their preventable health problems, secure compensation to pay for ongoing medical care and other Avandia side effects, and help prevent others from becoming victims.
Verdicts & Settlements |
Anapol TV |
Our Attorneys |
About Us |
Contact Us |
Site Map |
Avandia Lawsuits Site Map
Philadelphia, PA - Cherry Hill, NJ - Media, PA - Reading, PA - Harrisburg, PA
Copyright © - Anapol Schwartz - Pennsylvania Avandia Attorneys - Philadelphia Avandia Law Firm. All rights reserved.
Philadelphia Avandia Attorney Disclaimer: This website is dedicated to providing public information regarding Avandia and other legal information. None of the information on this site is intended to be formal legal advice, nor the formation of a lawyer or attorney client relationship. Please contact a Central Pennsylvania personal injury attorney or New Jersey Avandia lawyer at our law firm for information regarding your particular case. This website is not intended to solicit clients outside the States of New Jersey and Pennsylvania.